Our Mission

To accelerate patient access to gene and cell therapy with quality, speed, and agility

As the Gene and Cell Therapy field continues to evolve, the demand remains high for good quality and available production capacity, and the flexibility to support variety of technologies at different product stages. Patients in needs of the new therapeutic products demand them to be developed quickly and produced cost effectively.

ForeCyte Bio is established with the vision that every pharma/biotech has its own strength and expertise; let the expert amplify its expertise via collaborative work to accelerate the pace from drug discovery to patient access to the therapy. Our expertise is in the realm of plasmid, viral vector, and cell therapy production. Via our CDMO service, ForeCyte Bio is well positioned to help gene and cell therapy companies to accelerate their development process in terms of providing manufacturing expertise and capacity in preclinical, clinical, and commercial quantity GCT products.